Both in Pharmaceuticals
Relmada Therapeutics vs Altimmune
Over the past year RLMD returned +58.4% and ALT returned −49.6%; their daily moves had a correlation of 0.18.
RLMD +58.4% ALT −49.6%Growth of $1, one year, split-adjusted
| Metric | RLMD | ALT |
|---|---|---|
| Price | $3.58 | $2.04 |
| Market cap | $381.9M | $396.8M |
| Today | +4.07% | −4.67% |
| 1 month | −2.2% | −26.1% |
| 6 months | −53.1% | −27.7% |
| Year to date | −25.9% | −43.5% |
| 1 year | +46.1% | −49.0% |
| Revenue growth (YoY) | — | −100.0% |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | 12,800.5× |
| Net cash | $217.7M | $291.5M |
| Dividend yield | — | — |
| Volatility (60d) | 58.2% | 47.2% |
| Short % of float | 14.0% | 22.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).